Group Exercise Program for Prostate Cancer Survivors and Caregivers

N/A

Waitlist Available

Led By Meghan B Skiba, PhD, MS, MPH, RDN

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ability to ambulate (with or without assistive devices)

Histologically confirmed prostate cancer diagnosis (self-report)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

Awards & highlights

No Placebo-Only Group

Summary

This trial explores how an adapted group exercise program can improve physical/mental health of prostate cancer survivors & their informal caregivers. Participants will take part in supervised classes via videoconferencing for 3-months, with 3-months follow-up.

Who is the study for?

This trial is for Hispanic individuals who have completed primary treatment for prostate cancer at least 6 weeks ago and their caregivers, who can be anyone providing unpaid support. Participants must be over 18, understand English or Spanish, able to exercise and willing to attend online classes and complete surveys.

What is being tested?

The study tests the 'Exercising Together' program—a partnered resistance training routine conducted via videoconferencing software. It aims to improve physical and mental health of prostate cancer survivors and their caregivers over a period of 3 months with a follow-up after another 3 months.

What are the potential side effects?

Since this intervention involves exercise, potential side effects may include muscle soreness, fatigue, or injury related to physical activity. However, specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can walk by myself or with help from devices.

Select...

I have been diagnosed with prostate cancer.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and hr-qol will be measured over a 6 month period. it will be measured at baseline, 3 months, and 6 months. for reporting.